Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Diagnostics (Basel, Switzerland)|July 14, 2023
Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab MaintenanceCarole Durot, Eric Durot, Sébastien Mulé, et al.
Annals of Nuclear Medicine|May 25, 2021
18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphomaDavid Morland, Ghali Zizi, François Godard, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 6, 2025
Predictive factors for delayed high-dose methotrexate elimination: A practical issue for diffuse large B-cell lymphoma patientsMargot Vattaire-Hervé, Antoine Le Bozec, Justine Clarenne, et al.
Hematological Oncology|April 6, 2022
Does early disease progression predict survival after first line-treatment of Waldenström macroglobulinemia?Julien Labreuche, Deborah Assouan, Eric Durot, et al.
Hemasphere|May 1, 2023
Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and RituximabCyrielle Rodier, Lukshe Kanagaratnam, David Morland, et al.
Ejhaem|March 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World AnalysisThomas Hueso, Grégory Lazarian, Paul Chauvet, et al.
Haematologica|April 23, 2026
Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkin lymphoma: the LYSA real-world experienceGaetan Basile, Arnaud Neuville, Delphine Martineau, et al.
EJNMMI Research|May 27, 2024
Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective studyDavid Morland, Lukshe Kanagaratnam, Fabrice Hubelé, et al.
Hemasphere|January 30, 2023
Baseline <sup>18</sup>F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective StudyDavid Morland, Lukshe Kanagaratnam, Fabrice Hubelé, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2025
Waldenström's macroglobulinemia: The LYSA pragmatic guidelinesDamien Roos-Weil, Cécile Tomowiak, Stéphanie Poulain, et al.
Pageof 6